Non-Analgesic Effects of Opioids: Opioid-induced Nausea and Vomiting: Mechanisms and Strategies for their Limitation

Author(s): Flaminia Coluzzi, Alessandra Rocco, Ilenia Mandatori, Consalvo Mattia

Journal Name: Current Pharmaceutical Design

Volume 18 , Issue 37 , 2012

Become EABM
Become Reviewer


Nausea and vomiting are common gastrointestinal symptoms following opioid administration, for either chronic or acute pain management. As a consequence, patients’ dissatisfaction has a negative impact on treatment efficacy. A number of mechanisms have been identified, involving both central and peripheral sites. This article will review the pathophysiology of opioid-induced nausea and vomiting and the various pharmacological treatments currently available for its management. Preventive strategies and therapeutic approaches are evaluated in the perioperative setting and in chronic pain. Newer drugs include second generation serotonin receptor antagonists (palonosetron) and neurokinin-1 (NK-1) antagonists (aprepitant).

Keywords: Opioid, nausea, vomiting, postoperative, chemotherapy, neurokinin, serotonin, chemoreceptor trigger zone, pain, aprepitant.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Page: [6043 - 6052]
Pages: 10
DOI: 10.2174/138161212803582540
Price: $65

Article Metrics

PDF: 84